发明名称 METHOD OF DIAGNOSIS OF FIBROTIC DISEASES
摘要 The present invention relates to a new diagnosis method in the field of hepatology, combining measurement of serum markers and of liver elasticity.
申请公布号 US2014329260(A1) 申请公布日期 2014.11.06
申请号 US201214361998 申请日期 2012.11.30
申请人 Assistance Publique - Hôpitaux de Paris ;Biopredictive 发明人 Poynard Thierry
分类号 G06F19/18;C12Q1/48;G01N33/50 主分类号 G06F19/18
代理机构 代理人
主权项 1. An in vitro method for diagnosis of liver cirrhosis in a patient comprising the steps of: a) measuring the values of at alpha2-macroglobulin, haptoglobin, apolipoprotein-A1, total bilirubin, gamma-glutamyl-transpeptidase (GGT) in the serum or plasma of said patient, and combining said values through a first logistic function including said markers, the age and sex of said patient, wherein said first logistic function is 4.467×Log(Alpha2Macroglobulin (g/l))−1.357×Log(Haptoglobin (g/l))+1.017×Log(GGT (IU/l))+0.0281×Age (in years)+1.737×Log(Bilirubin (μmol/l))−1.184×ApoA1 (g/l)+0.301×Sex (female=0, male=1)−5.540, and obtaining a first index b) measuring liver stiffness for said patient by Vibration Controlled Transient Elastography and obtaining a second index c) combining said first and second index through a second logistic function in order to obtain a final index, wherein said second logistic function is a1+a2×[first index]+a3×[second index] wherein a1 is comprised between −9.27 and −9.07; a2 is comprised between 3.08 and 3.1; a3 is comprised between 5.67 and 5.87.
地址 Paris FR